What drug enhances the output of respiratory tract fluid by reducing the adhesiveness and surface tension of the fluid which facilitates the removal of viscous mucus?
Guaifenesin.
Dextromethorphan.
Acetylcysteine.
Flunisolide.
The Correct Answer is A
Choice A rationale
Guaifenesin is an expectorant that increases the output of respiratory tract fluid by reducing the adhesiveness and surface tension of the mucus, facilitating the removal of viscous mucus.
Choice B rationale
Dextromethorphan is a cough suppressant that works on the cough center in the brain to reduce the urge to cough. It does not enhance the output of respiratory tract fluid.
Choice C rationale
Acetylcysteine is a mucolytic that breaks down the chemical structure of mucus molecules, making the mucus less viscous, but it does not enhance the output of respiratory tract fluid by reducing adhesiveness.
Choice D rationale
Flunisolide is an inhaled corticosteroid used to reduce inflammation in the airways. It does not enhance the output of respiratory tract fluid.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A rationale
Exhibiting the ability to provide self-care may not be realistic for a patient with advanced Alzheimer’s disease. Cognitive decline may impair their ability to perform daily activities independently, necessitating assistance from caregivers.
Choice B rationale
Improving memory for recent events is unlikely in advanced Alzheimer’s disease, as the condition typically involves progressive memory loss and cognitive decline. New medications may help manage symptoms, but reversing memory loss is not a realistic goal.
Choice C rationale
Receiving appropriate assistance for care needs is a realistic and achievable goal for patients with advanced Alzheimer’s disease. As the disease progresses, patients will require increasing levels of support to ensure their safety and well-being.
Choice D rationale
Demonstrating improved cognitive function is unlikely in advanced Alzheimer’s disease. While medications may help manage symptoms, the progressive nature of the disease means that cognitive decline will continue, and improvement is not a realistic expectation.
Correct Answer is A
Explanation
Choice A rationale
Sumatriptan (Imitrex) is a selective serotonin receptor agonist that helps constrict blood vessels in the brain and is typically used to treat migraine and cluster headaches. Its effectiveness is due to its ability to reduce inflammation and alleviate the pain associated with these headaches.
Choice B rationale
Naratriptan (Amerge) is also a triptan used for the treatment of migraines but is not specifically indicated for cluster headaches.
Choice C rationale
Frovatriptan (Frova) is used mainly for the acute treatment of migraine headaches and is not indicated for cluster headaches.
Choice D rationale
Almotriptan (Axert) is used to treat migraines and does not have an indication for cluster headaches.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.